Back to Search
RACHELLE DOODY, MD, PHD
MD, PHD
Neurology Physician
NPI: 1457431793Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
G4994(TX)
Research & Publications (20)
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
PMID 19176895·Neurology·2009
4-observational
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
PMID 19328443·Alzheimers Dement·2009
8-other
We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease drug development.
PMID 18631995·Alzheimers Dement·2008
8-other
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.
PMID 18640457·Lancet·2008
4-observational
Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.
PMID 18257603·Drugs Aging·2008
4-observational
Meta-analysis of six-month memantine trials in Alzheimer's disease.
PMID 19595910·Alzheimers Dement·2007
8-other
Changing patient characteristics and survival experience in an Alzheimer's center patient cohort.
PMID 16088145·Dement Geriatr Cogn Disord·2005
8-other
Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.
PMID 15256834·Dement Geriatr Cogn Disord·2004
4-observational
A method for estimating duration of illness in Alzheimer's disease.
PMID 14560058·Dement Geriatr Cogn Disord·2004
8-other
Current treatments for Alzheimer's disease: cholinesterase inhibitors.
PMID 12934969·J Clin Psychiatry·2003
6-review
Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.
PMID 11255446·Arch Neurol·2001
3-trial
A method for estimating progression rates in Alzheimer disease.
PMID 11255449·Arch Neurol·2001
3-trial
Practice parameter: management of dementia (an evidence-based review) [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of Neurology.
PMID 11342679·Neurology·2001
6-review
Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?
PMID 11032626·J Neurol Neurosurg Psychiatry·2000
8-other
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
PMID 19328434·Alzheimers Dement·2009
8-other
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors.
PMID 19328439·Alzheimers Dement·2009
8-other
How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
PMID 19641319·Dement Geriatr Cogn Disord·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6550 FANNIN ST, SUITE 1801
HOUSTON, TX 77030 - Phone
- (713) 798-5975
Quick Facts
- NPI
- 1457431793
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile